GBX1
Homeobox protein GBX-1
Also known as: GBX1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14549
- Gene
- GBX1
- Ensembl
- ENSG00000164900
- Chromosome
- 7
- Canonical length
- 363 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of nervous system development and regulation of transcription by RNA polymerase II. Predicted to act upstream of or within adult walking behavior; neuron differentiation; and proprioception. Predicted to be located in chromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
363 residues, UniProt reviewed canonical sequence.
>Q14549|GBX1
1 MQRAGGGSAP GGNGGGGGGG PGTAFSIDSL IGPPPPRSGH LLYTGYPMFM PYRPLVLPQA
61 LAPAPLPAGL PPLAPLASFA GRLTNTFCAG LGQAVPSMVA LTTALPSFAE PPDAFYGPQE
121 LAAAAAAAAA TAARNNPEPG GRRPEGGLEA DELLPAREKV AEPPPPPPPH FSETFPSLPA
181 EGKVYSSDEE KLEASAGDPA GSEQEEEGSG GDSEDDGFLD SSAGGPGALL GPKPKLKGSL
241 GTGAEEGAPV TAGVTAPGGK SRRRRTAFTS EQLLELEKEF HCKKYLSLTE RSQIAHALKL
301 SEVQVKIWFQ NRRAKWKRIK AGNVSSRSGE PVRNPKIVVP IPVHVNRFAV RSQHQQMEQG
361 ARPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GBX1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.68
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 11 nTPM
- testis: 7.6 nTPM
- tongue: 1 nTPM
- heart muscle: 0.8 nTPM
- basal ganglia: 0.1 nTPM
- hypothalamus: 0.1 nTPM
Single-cell type
- myonuclei: 290 nCPM
- early primary spermatocytes: 135 nCPM
- differentiating spermatogonia: 27 nCPM
- cardiomyocytes: 22 nCPM
- late primary spermatocytes: 21 nCPM
- epicardial cells: 9.1 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- spinal cord: 2.4 nTPM
- medulla oblongata: 2 nTPM
- cerebral cortex: 1.9 nTPM
- hypothalamus: 1.7 nTPM
- hippocampal formation: 0.8 nTPM
- basal ganglia: 0.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.67
- gnomAD pLI
- 0.41
- gnomAD missense Z
- 0.82
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adult walking behavior
- neuron fate commitment
- proprioception
- regulation of nervous system development
- regulation of transcription by RNA polymerase II
- sensory neuron axon guidance
- spinal cord motor neuron differentiation
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GBX1 as an antibody target. Whether an autoantibody or antibody against GBX1 could matter depends on whether native GBX1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GBX1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GBX1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...